Dark

TBPH
Theravance Biopharma, Inc.
stock NASDAQ

At Close

Mar 3, 2026 3:59:57 PM EST

13.97USD-26.306%(-4.98)4,387,270

13.96Bid 13.99Ask 0.03Spread

Pre-market

Mar 3, 2026 9:28:30 AM EST

14.07USD-25.752%(-4.88)161,495

After-hours

Mar 3, 2026 4:56:30 PM EST

13.65USD-2.256%(-0.32)5,800

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

707.13M

CEO

Rick Winningham

Headquarters

George Town, Grand Cayman, Cayman Islands

Industry

Biotechnology

CORT CPIX COLL XLV

TBPH Stats

Avg. Vol. 10 Day

619,106

Avg. Vol. 30 Day

457,170

Employees

340

Market Cap

707,133,775

Shares Out.

50,672,431

On/Off Exchange

63%/37%

6 Month Beta

0.64

1 Year Beta

0.49

2 Year Beta

0.53

3 Year Beta

0.53

52 Week Low

7.90

52 Week High

21.03

SMA50

19.29

SMA200

14.88

1 Week

-26.78%

1 Month

-30.19%

3 Month

-26.13%

6 Month

+1.60%

1 Year

+52.51%

2 Year

+53.35%

5 Year

-26.24%

Profile

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

TBPH Stock Summary

Theravance Biopharma, Inc. (NASDAQ:TBPH) stock price today is $13.97, and today's volume is 4,387,270. TBPH is down -26.306% today. The 30 day average volume is 457,170. TBPH market cap is 707.13M with 50,672,431 shares outstanding.